4.2 Article

An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

Coronary heart disease outcomes in patients receiving antidiabetic agents

Andrew T. McAfee et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)

Article Public, Environmental & Occupational Health

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy

Catherine B. Johannes et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)